Profusa (NASDAQ: PFSA) is quickly building momentum across Europe, adding leading vascular specialists to its clinical network while also preparing…
Read More »Top Stories
Gold (XAUUSD) has shattered yet another record, closing above $3,560 an ounce and cementing its role as 2025’s standout asset.…
Read More »Rezolve AI (NASDAQ: RZLV) is a generative AI company disrupting the retail and e-commerce landscape. With strategic alliances, fresh capital,…
Read More »Polymarket, the blockchain-based prediction platform once forced to block American users, has secured the long-awaited green light to reenter the…
Read More »Solidion Technology (NASDAQ: STI) lit up the market on Wednesday, soaring 113% after announcing its latest recognition in the clean…
Read More »Why Profusa Stands Out in Small-Cap Investing Profusa (NASDAQ: PFSA) is a biotech company that is developing tissue‑integrating biosensors for…
Read More »Bitcoin (BTCUSD) climbed as high as $124,200 on August 14, touching another record high as investors embraced riskier assets amid…
Read More »Tharimmune (NASDAQ: THAR) stunned Wall Street on Wednesday, with its stock surging more than 200% after announcing positive simulation results…
Read More »For years, congressional stock trading has sparked outrage, suspicion, and fascination. Some lawmakers and their spouses appear to have uncanny…
Read More »Profusa (NASDAQ: PFSA) is ramping up its leadership team just as the company accelerates efforts to commercialize its groundbreaking biosensor…
Read More »









